Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives

Overview

Journal Annu Rev Public Health

Specialty Public Health

Date 2018 Jan 12

PMID 29323611

Citations 135

Authors

David B Abrams

Allison M Glasser

Jennifer L Pearson

Andrea C Villanti

Lauren K Collins

Raymond S Niaura

Affiliations

Soon will be listed here.

Abstract

Inhalation of the toxic smoke produced by combusting tobacco products, primarily cigarettes, is the overwhelming cause of tobacco-related disease and death in the United States and globally. A diverse class of alternative nicotine delivery systems (ANDS) has recently been developed that do not combust tobacco and are substantially less harmful than cigarettes. ANDS have the potential to disrupt the 120-year dominance of the cigarette and challenge the field on how the tobacco pandemic could be reversed if nicotine is decoupled from lethal inhaled smoke. ANDS may provide a means to compete with, and even replace, combusted cigarette use, saving more lives more rapidly than previously possible. On the basis of the scientific evidence on ANDS, we explore benefits and harms to public health to guide practice, policy, and regulation. A reframing of societal nicotine use through the lens of harm minimization is an extraordinary opportunity to enhance the impact of tobacco control efforts.

Citing Articles

Switching behavior and changes in smoking behavior by menthol cigarette preference and menthol heated tobacco product use among adults in the United States who smoke cigarettes: an actual use study.

Karelitz J, He Y, Becker E, Vansickel A Harm Reduct J. 2025; 22(1):19.

PMID: 39980000 PMC: 11841305. DOI: 10.1186/s12954-025-01170-7.

Tobacco Use, Risk Perceptions, and Characteristics of Adults Who Used a Heated Tobacco Product (IQOS) in the United States: Cross-Sectional Survey Study.

Cheng H, Noggle B, Vansickel A, Largo E, Magnani P JMIR Form Res. 2025; 9:e57398.

PMID: 39919732 PMC: 11845882. DOI: 10.2196/57398.

E-Cigarette switching and financial incentives to promote combustible cigarette cessation among adults accessing shelter services: A pilot study.

Sifat M, Alexander A, Businelle M, Frank-Pearce S, Boozary L, Wagener T Drug Alcohol Depend Rep. 2025; 13:100295.

PMID: 39764385 PMC: 11702002. DOI: 10.1016/j.dadr.2024.100295.

Smoking cessation and harm reduction: a systematic overview of ongoing, randomized controlled trials.

Derissen M, Scheliga S, Clemens B, Leiding D, Kroger K, Bohner H BMC Psychiatry. 2024; 24(1):897.

PMID: 39690417 PMC: 11650832. DOI: 10.1186/s12888-024-06342-6.

toxicological evaluation of pouched portioned oral nicotine products.

Keyser B, Leverette R, McRae R, Wertman J, Shutsky T, Szeliga K Front Toxicol. 2024; 6:1452274.

PMID: 39669663 PMC: 11634830. DOI: 10.3389/ftox.2024.1452274.

References

Villanti A, Pearson J, Glasser A, Johnson A, Collins L, Niaura R . Frequency of Youth E-Cigarette and Tobacco Use Patterns in the United States: Measurement Precision Is Critical to Inform Public Health. Nicotine Tob Res. 2016; 19(11):1345-1350. PMC: 5896511. DOI: 10.1093/ntr/ntw388. View

Abrams D . Potential and pitfalls of e-cigarettes--reply. JAMA. 2014; 311(18):1922-3. DOI: 10.1001/jama.2014.2999. View

Levy D, Borland R, Villanti A, Niaura R, Yuan Z, Zhang Y . The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States. Nicotine Tob Res. 2016; 19(2):149-159. PMC: 5234365. DOI: 10.1093/ntr/ntw158. View

Cobb N, Abrams D . The FDA, e-cigarettes, and the demise of combusted tobacco. N Engl J Med. 2014; 371(16):1469-71. DOI: 10.1056/NEJMp1408448. View

Lee P . Epidemiological evidence relating snus to health--an updated review based on recent publications. Harm Reduct J. 2013; 10:36. PMC: 4029226. DOI: 10.1186/1477-7517-10-36. View

Majeed B, Weaver S, Gregory K, Whitney C, Slovic P, Pechacek T . Changing Perceptions of Harm of E-Cigarettes Among U.S. Adults, 2012-2015. Am J Prev Med. 2017; 52(3):331-338. PMC: 5373478. DOI: 10.1016/j.amepre.2016.08.039. View

Wills T, Sargent J, Gibbons F, Pagano I, Schweitzer R . E-cigarette use is differentially related to smoking onset among lower risk adolescents. Tob Control. 2016; 26(5):534-539. PMC: 5537057. DOI: 10.1136/tobaccocontrol-2016-053116. View

Talati A, Keyes K, Hasin D . Changing relationships between smoking and psychiatric disorders across twentieth century birth cohorts: clinical and research implications. Mol Psychiatry. 2016; 21(4):464-71. PMC: 4801658. DOI: 10.1038/mp.2015.224. View

Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J . Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382(9905):1629-37. DOI: 10.1016/S0140-6736(13)61842-5. View

10.

Gitchell J, Shiffman S, Sembower M . Trends in serious quit attempts in the United States, 2009-14. Addiction. 2016; 112(5):897-900. DOI: 10.1111/add.13712. View

11.

Fagerstrom K, Bridgman K . Tobacco harm reduction: the need for new products that can compete with cigarettes. Addict Behav. 2013; 39(3):507-11. DOI: 10.1016/j.addbeh.2013.11.002. View

12.

Polosa R, Campagna D, Sands M . Counseling patients with asthma and allergy about electronic cigarettes: an evidence-based approach. Ann Allergy Asthma Immunol. 2015; 116(2):106-11. DOI: 10.1016/j.anai.2015.10.012. View

13.

Lee P . Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol. 2010; 59(2):197-214. DOI: 10.1016/j.yrtph.2010.12.002. View

14.

Kozlowski L, Warner K . Adolescents and e-cigarettes: Objects of concern may appear larger than they are. Drug Alcohol Depend. 2018; 174:209-214. DOI: 10.1016/j.drugalcdep.2017.01.001. View

15.

Farsalinos K, Poulas K, Voudris V, Le Houezec J . Prevalence and correlates of current daily use of electronic cigarettes in the European Union: analysis of the 2014 Eurobarometer survey. Intern Emerg Med. 2017; 12(6):757-763. DOI: 10.1007/s11739-017-1643-7. View

16.

Warner K . An endgame for tobacco?. Tob Control. 2013; 22 Suppl 1:i3-5. PMC: 3632965. DOI: 10.1136/tobaccocontrol-2013-050989. View

17.

Lee P, Hamling J . Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med. 2009; 7:36. PMC: 2744672. DOI: 10.1186/1741-7015-7-36. View

18.

Russell M . Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J. 1976; 1(6023):1430-3. PMC: 1640397. DOI: 10.1136/bmj.1.6023.1430. View

19.

Nutt D, Phillips L, Balfour D, Curran H, Dockrell M, Foulds J . Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014; 20(5):218-25. DOI: 10.1159/000360220. View

20.

Hecht S, Carmella S, Kotandeniya D, Pillsbury M, Chen M, Ransom B . Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res. 2014; 17(6):704-9. PMC: 4481723. DOI: 10.1093/ntr/ntu218. View